Percutaneous Revascularization of Left Main Disease: Could the Angiographic Follow-Up Improve the Survival?

Free article

Comment

Iñigo Lozano et al. J Am Coll Cardiol. 2017.

Free article

. 2017 Feb 7;69(5):597-598.

doi: 10.1016/j.jacc.2016.09.986.

No abstract available

Comment in

Reply: Percutaneous Revascularization of Left Main Disease: Could the Angiographic Follow-Up Improve the Survival?
Cavalcante R, Sotomi Y, Lee CW, Ahn JM, Onuma Y, Park SJ, Serruys PW. Cavalcante R, et al. J Am Coll Cardiol. 2017 Feb 7;69(5):598. doi: 10.1016/j.jacc.2016.10.075. J Am Coll Cardiol. 2017. PMID: 28153116 No abstract available.

Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease.
Cavalcante R, Sotomi Y, Lee CW, Ahn JM, Farooq V, Tateishi H, Tenekecioglu E, Zeng Y, Suwannasom P, Collet C, Albuquerque FN, Onuma Y, Park SJ, Serruys PW. Cavalcante R, et al. J Am Coll Cardiol. 2016 Sep 6;68(10):999-1009. doi: 10.1016/j.jacc.2016.06.024. J Am Coll Cardiol. 2016. PMID: 27585503 Clinical Trial.
Myocardial Revascularization for Left Main Coronary Artery Disease: A Step Toward Individualized Treatment Selection.
Windecker S, Piccolo R. Windecker S, et al. J Am Coll Cardiol. 2016 Sep 6;68(10):1010-3. doi: 10.1016/j.jacc.2016.06.043. J Am Coll Cardiol. 2016. PMID: 27585504 No abstract available.